Advanced search
Publication Cover
Nanomedicine Volume 5, 2010 - Issue 3
Submit an article Journal homepage
669
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease

Anna M Brynskikh2 Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Yuling Zhao1 Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.;2 Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
R Lee Mosley2 Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Shu Li1 Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.View further author information
,
Michael D Boska2 Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Natalia L Klyachko3 Deparment of Chemistry, MV Lomonosov State University, Moscow, RussiaView further author information
,
Alexander V Kabanov1 Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.View further author information
,
Howard E Gendelman2 Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USAView further author information
&
Elena V Batrakova1 Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.Correspondence[email protected]
View further author information
 show all
Pages 379-396 | Published online: 16 Apr 2010

Bibliography

  • Lees A j, Hardy J, Revesz T: Parkinson‘s disease. Lancet373(9680), 2055–2066 (2009).
  • Gonzalez-Polo RA , SolerG, RodriguezmartinA, MoranJM, FuentesJM: Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants.Cell. Biol. Int.28(5), 373–380 (2004).
  • Jain S , MishraV, SinghP, DubeyPK, SarafDK, VyasSP: RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting.Int. J. Pharm.261(1–2), 43–55 (2003).
  • Kao WJ , LiuY, GundlooriRet al.: Engineering endogenous inflammatory cells as delivery vehicles.J. Control Release78(1–3), 219–233 (2002).
  • Begley DJ : Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.Pharmacol. Ther.104(1), 29–45 (2004).
  • Batrakova EV , LiS, ReynoldsADet al.: A macrophage–nanozyme delivery system for Parkinson‘s disease.Bioconjug. Chem.18(5), 1498–1506 (2007).
  • Lossinsky AS , ShiversRR: Structural pathways for macromolecular and cellular transport across the blood–brain barrier during inflammatory conditions. Review.Histol. Histopathol.19(2), 535–564 (2004).
  • Pawlowski NA , KaplanG, AbrahamE, CohnZA: The selective binding and transmigration of monocytes through the junctional complexes of human endothelium.J. Exp. Med.168(5), 1865–1882 (1988).
  • Kuby J : Immunology . Kindt TJ, Goldsby RA, Osborne BA (Eds). WH Freeman WH, NY, USA (1994).
  • Daleke DL , HongK, PapahadjopoulosD: Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay.Biochim. Biophys. Acta1024(2), 352–366 (1990).
  • Lee KD , HongK, PapahadjopoulosD: Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density.Biochim. Biophys. Acta1103(2), 185–197 (1992).
  • Nishikawa K , AraiH, InoueK: Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages.J. Biol. Chem.265(9), 5226–5231 (1990).
  • Fujiwara M , BaldeschwielerJD, GrubbsRH: Receptor-mediated endocytosis of poly(acrylic acid)-conjugated liposomes by macrophages.Biochim. Biophys. Acta1278(1), 59–67 (1996).
  • Nguyen HK , LemieuxP, VinogradovSVet al.: Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents.Gene Ther.7(2), 126–138 (2000).
  • Vinogradov S , BronichT, KabanovA: Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides.Bioconjugate Chemistry9(6), 805–812 (1998).
  • Dou H , DestacheCJ, MoreheadJRet al.: Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.Blood108(8), 2827–2835 (2006).
  • Seguin R , BiernackiK, RotondoRL, PratA, AntelJP: Regulation and functional effects of monocyte migration across human brain-derived endothelial cells.J. Neuropathol. Exp. Neurol.62(4), 412–419 (2003).
  • Zelivyanskaya ML , NelsonJA, PoluektovaLet al.: Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging.J. Neurosci. Res.73(3), 284–295 (2003).
  • Weidenfeller C , SchrotS, ZozulyaA, GallaHJ: Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone.Brain Res.1053(1–2), 162–174 (2005).
  • Batrakova E , HanH, MillerD, KabanovA: Effects of pluronic p85 unimers and micelles on drug permeability in polarized bbmec and caco-2 cells.Pharm. Res.15(10), 1525–1532 (1998).
  • Batrakova E , LiS, MillerD, KabanovA: Pluronic p85 increases permeability of a broad spectrum of drugs in polarized BBMEC and caco-2 cell monolayers.Pharm. Res.16(9), 1366–1372 (1999).
  • Benner EJ , MosleyRL, DestacheCJet al.: Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson‘s disease.Proc. Natl Acad. Sci. USA101(25), 9435–9440 (2004).
  • Jackson-Lewis V , PrzedborskiS: Protocol for the mptp mouse model of Parkinson‘s disease.Nat. Protoc.2(1), 141–151 (2007).
  • Tieu K , PerierC, CaspersenCet al.: D-β-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.J. Clin. Invest.112(6), 892–901 (2003).
  • Liberatore GT , Jackson-LewisV, VukosavicSet al.: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.Nat. Med.5(12), 1403–1409 (1999).
  • Boska MD , LewisTB, DestacheCJet al.: Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson‘s disease.J. Neurosci.25(7), 1691–1700 (2005).
  • Hetherington HP , PanJW, MasonGFet al.: 2D 1H spectroscopic imaging of the human brain at 4.1 T.Magn. Reson. Med.32(4), 530–534 (1994).
  • Glass JD , FedorH, WesselinghSL, McArthurJC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.Ann. Neurol.38(5), 755–762 (1995).
  • Liu B , HongJS: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.J. Pharmacol. Exp. Ther.304(1), 1–7 (2003).
  • Stone DK , ReynoldsAD, MosleyRL, GendelmanHE: Innate and adaptive immunity for the pathobiology of Parkinson‘s disease.Antioxid. Redox Signal11(9), 2151–2166 (2009).
  • Ebadi M , SrinivasanSK, BaxiMD: Oxidative stress and antioxidant therapy in Parkinson‘s disease.Prog. Neurobiol.48(1), 1–19 (1996).
  • Wu DC , TeismannP, TieuKet al.: NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson‘s disease.Proc. Natl Acad. Sci. USA100(10), 6145–6150 (2003).
  • Navarro A , BoverisA: Brain mitochondrial dysfunction and oxidative damage in Parkinson‘s disease.J. Bioenerg. Biomembr.41(6), 517–521 (2009).
  • Zarkovic N : 4-hydroxynonenal as a bioactive marker of pathophysiological processes.Mol. Aspects Med.24(4–5), 281–291 (2003).
  • Mcgeer PL , ItagakiS, BoyesBE, McGeerEG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson‘s and Alzheimer‘s disease brains.Neurology38(8), 1285–1291 (1988).
  • Busciglio J , YanknerBA: Apoptosis and increased generation of reactive oxygen species in Down‘s syndrome neurons in vitro.Nature378(6559), 776–779 (1995).
  • Boje KM , AroraPK: Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death.Brain Res.587(2), 250–256 (1992).
  • Chao CC , HuS, MolitorTW, ShaskanEG, PetersonPK: Activated microglia mediate neuronal cell injury via a nitric oxide mechanism.J. Immunol.149(8), 2736–2741 (1992).
  • Mcguire SO , LingZD, LiptonJW, SortwellCE, CollierTJ, CarveyPM: Tumor necrosis factor a is toxic to embryonic mesencephalic dopamine neurons.Exp. Neurol.169(2), 219–230 (2001).
  • Whitton PS : Inflammation as a causative factor in the aetiology of Parkinson‘s disease.Br. J. Pharmacol.150(8), 963–976 (2007).
  • Simone EA , DziublaTD, Colon-GonzalezF, DischerDE, MuzykantovVR: Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers.Biomacromolecules8(12), 3914–3921 (2007).
  • Siwale RC , OettingerCW, Balakrishna Pai S et al.: Formulation and characterization of catalase in albumin microspheres. J. Microencapsul.1–9 (2008).
  • Prasad KN , ColeWC, HovlandARet al.: Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale.Curr. Opin. Neurol.12(6), 761–770 (1999).
  • Beal MF , MatthewsRT: Coenzyme q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.Mol. Aspects Med.18(Suppl.) S169–S179 (1997).
  • Zhao K , LuoG, GiannelliS, SzetoHH: Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines.Biochem. Pharmacol.70(12), 1796–1806 (2005).
  • Dou H , GrotepasCB, McMillanJMet al.: Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroaids.J. Immunol.183(1), 661–669 (2009).
  • Hendriks JJ , TeunissenCE, De Vries HE, Dijkstra CD: Macrophages and neurodegeneration. Brain Res. Rev.48(2), 185–195 (2005).
  • Langston JW , IrwinI: MPTP: current concepts and controversies.Clin. Neuropharmacol.9(6), 485–507 (1986).
  • Langston JW , FornoLS, TetrudJ, ReevesAG, KaplanJA, KarlukD: Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.Ann. Neurol.46(4), 598–605 (1999).
  • Schmidt N , FergerB: Neurochemical findings in the MPTP model of Parkinson‘s disease.J. Neural Transm.108(11), 1263–1282 (2001).
  • Kokovay E , CunninghamLA: Bone marrow-derived microglia contribute to the neuroinflammatory response and express INOS in the MPTP mouse model of Parkinson‘s disease.Neurobiol. Dis.19(3), 471–478 (2005).
  • Mosley R , BennerE, KadiuIet al.: Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson‘s disease.Clin. Neurosci. Res.6(5), 261–281 (2006).
  • Audoy-Remus J , RichardJF, SouletD, ZhouH, KubesP, VallieresL: Rod-shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2.J. Neurosci.28(41), 10187–10199 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.